Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)

Hospital


Location: Montpellier, France (FR) FR

ISNI: 000000009961060X

ROR: https://ror.org/00mthsf17

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Imbalances in protein homeostasis caused by mutant desmin (2019) Clemen C, Winter L, Unger A, Berwanger C, Spörrer M, Linke W, Schröder R Conference contribution Malignant cardiac phenotype after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous R349P desmin knock-in mice (2019) Stoeckigt F, Eichhorn L, Beiert T, Knappe V, Radecke T, Steinmetz M, Berwanger C, et al. Conference contribution Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT (2019) Nagler A, Labopin M, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, et al. Conference contribution A Phase 2 Study of Galunisertib (TGF-beta 1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (2019) Kelley RK, Gane E, Assenat E, Galle PR, Merle P, Hourmand IO, Cleverly A, et al. Journal article Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms (2019) Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, et al. Journal article Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention (2019) Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases (2018) Wermann WK, Viardot A, Kayser S, Alakel N, Elmaagacli A, Faul C, Fiedler W, et al. Conference contribution Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study (2018) Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe (2018) Tarr R, Hsu D, Kulcsar Z, Bonvin C, Rufenacht D, Alfke K, Stingele R, et al. Journal article Fear of progression in patients with low-risk malignant melanoma (2017) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Conference contribution
1 ... 3 4 5 6 7